ClinConnect ClinConnect Logo
Search / Trial NCT06857344

Reinforcement Learned Automatic Anesthesia System During Painless Gastrointestinal Endoscopy

Launched by BOSTON INTELLIGENT MEDICAL RESEARCH CENTER, SHENZHEN UNITED SCHEME TECHNOLOGY CO., LTD. · Feb 26, 2025

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating a new approach to administering anesthesia during a procedure called gastrointestinal endoscopy, which helps doctors examine the digestive system. The researchers want to see if an artificial intelligence (AI) system can safely and effectively manage anesthesia, just like trained healthcare professionals do. They will compare the performance of the AI with that of the doctors to find out if both can achieve similar success rates in keeping patients comfortable and safe during the procedure.

To participate in this trial, adults aged 18 to 65 with a low risk of health issues (classified as ASA I-II) may be eligible. However, individuals with certain conditions like heart rhythm problems, allergies to specific medications, or those who are pregnant or breastfeeding cannot take part. If you join the study, you'll need to fast for 8 hours beforehand and avoid drinking water for 2 hours after taking a preparation to clean out your intestines. This trial is not yet recruiting participants, but it aims to learn more about the role of AI in healthcare.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • American Society of Anesthesiologists (ASA) physical status class I-II
  • Expected operation duration less than 1 hour
  • Exclusion Criteria:
  • History of cardiac, hepatic, renal, or metabolic disorders (e.g., diabetes, hypertension, sleep apnea)
  • Known allergy to opioids or ciprofloxacin components
  • Cachexia
  • Hypothermia; history of narcotic abuse; chronic alcoholism; obesity (BMI \>30); patients with apnea
  • Current pregnancy or lactation
  • History of substance abuse or alcohol dependence
  • Participation in any other drug clinical trial within the past 3 months
  • Obesity (BMI \>30 kg/m²)
  • Procedure termination due to gastric retention or inadequate bowel preparation

About Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.

Boston Intelligent Medical Research Center, in collaboration with Shenzhen United Scheme Technology Co., Ltd., is a pioneering organization dedicated to advancing healthcare through innovative clinical research. With a focus on developing cutting-edge medical technologies and solutions, the center combines rigorous scientific methodology with state-of-the-art technology to facilitate groundbreaking studies. Their commitment to enhancing patient outcomes and improving clinical practices positions them as a key player in the global medical research landscape, fostering partnerships that drive excellence in healthcare delivery and innovation.

Locations

Zhengzhou, Henan, China

Zhengzhou, Henan, China

Anxi, Fujian, China

Jinjiang, Fujian, China

Xinzheng, Henan, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported